Potential Drug Molecules

This page provides information about the potential drug molecules for Mucormycosis.

Protein Name	Uniprot ID	Drug	DrugBank ID	Action	Use
CYP51	A0A2U8U7V7_RHIOR	Miconazole	DB01110	Inhibitor	Used to treat fungal infections affecting the vagina, mouth and skin, including candidiasis.
CYP51	A0A2U8U7V7_RHIOR	Oxiconazole	DB00239	Inhibitor	Used in the treatment of various skin infections such as athlete's foot, jock itch and ringworm.
CYP51	A0A2U8U7V7_RHIOR	Fluconazole	DB00196	Inhibitor	Used for the treatment of both systemic and superficial fungal infections in a variety of tissues.
CYP51	A0A2U8U7V7_RHIOR	Bifonazole	DB04794	Inhibitor	Used to treat fungal skin infections, such as dermatomycosis.
CYP51	A0A2U8U7V7_RHIOR	Sertaconazole	DB01153	Inhibitor	Used in the treatment of interdigital tinea pedis in immunocompetent patients..
CYP51	A0A2U8U7V7_RHIOR	Clotrimazole	DB00257	Antagonist/inhibitor	Used for the treatment of a wide variety of dermatophyte infections and candidiasis.
CYP51	A0A2U8U7V7_RHIOR	Econazole	DB01127	Antagonist	Used to treat tinea pedis, tinea cruris, tinea corporis, cutaneous candidiasis and tinea versicolor.
CYP51	A0A2U8U7V7_RHIOR	Posaconazole	DB01263	Antagonist	Used to treat invasive infections by Candida species and Aspergillus species in severely immunocompromised patients.
CYP51	A0A2U8U7V7_RHIOR	Terconazole	DB00251	Antagonist	Used in the treatment of vulvovaginal candidiasis.
CYP51	A0A2U8U7V7_RHIOR	Tioconazole	DB01007	Antagonist	Used to treat vulvovaginal candidiasis..
CYP51	A0A2U8U7V7_RHIOR	Voriconazole	DB00582	Antagonist/inhibitor	Used to treat fungal infections.
CYP51	A0A2U8U7V7_RHIOR	Luliconazole	DB08933	Inhibitor	Used to treat fungal infections.
CYP51	A0A2U8U7V7_RHIOR	Oteseconazole	DB13055	Inhibitor	Used to prevent recurrent vulvovaginal candidiasis in females who are not of reproductive potential.
CYP51	A0A2U8U7V7_RHIOR	Itraconazole	DB01167	Inhibitor	Used for the treatment of various fungal infections in immunocompromised and non-immunocompromised patients, such as pulmonary and extrapulmonary blastomycosis, histoplasmosis, and onychomycosis.
CYP51	A0A2U8U7V7_RHIOR	Ketoconazole	DB01026	Inhibitor	Used to treat seborrheic dermatitis and fungal skin infections.
CYP51	A0A2U8U7V7_RHIOR	Efinaconazole	DB09040	Inhibitor	Used to treat onychomycosis, a fungal infection of the nail.
CYP51	A0A2U8U7V7_RHIOR	Isavuconazole	DB11633	Inhibitor	Used for treatment of invasive aspergillosis and mucormycosis
CYP51	A0A2U8U7V7_RHIOR	Sulconazole	DB06820	Inhibitor	Used for the treatment of tinea cruris, tinea corporis, and tinea versicolor caused by susceptible fungal strains.
ARF	I1C4D3_RHIO9	Chlortetracycline	DB09093	Inhibitor	Used for veterinary purposes.
ARF	I1C4D3_RHIO9	Artenimol	DB11638	Ligand	Used in the treatment of uncomplicated Plasmodium falciparum infections
DHD	I1CS69_RHIO9	Glycine	DB00145	Substrate	Used as a component of total parenteral nutrition and is also used as irrigation during surgery.
CaN	I1CTP1_RHIO9	Voclosporin	DB11693	Inhibitor	Used in the treatment of lupus nephritis (LN) in patients diagnosed with systemic lupus erythematosus (SLE).
CaN	I1CTP1_RHIO9	Cyclosporine	DB00091	Inhibitor	Used in organ and bone marrow transplants as well as inflammatory conditions such as ulcerative colitis, rheumatoid arthritis, and atopic dermatitis.